PMA device
Cordis Precise Nitinol Stent
Cordis US Corporation · Stent, Carotid (NIM, Class III) · First FDA decision Sep 22, 2006, newest Apr 14, 2008Carotid artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
5
Naming "Precise Nitinol"
MAUDE reports
0
Brand "Precise Nitinol", since 2015
PubMed studies
5
Mentioning "Precise Nitinol"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cordis Precise Nitinol Stent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CORDIS PRECISE NITINOL STENTPMA supplement
P030047-S009 · Decided Apr 14, 2008 · 145 days after receipt · Normal 180 Day Track No User Fee
Device type: Stent, carotid (NIM) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R8Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R7Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R6Updated Sep 21, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085R3Updated Sep 21, 2026
- Carotid Artery Stenting in Post-Approval StudiesNational analysisReview closedCAG-00259NUpdated Sep 17, 2026
- Carotid Artery StentingNational analysisReview closedCAG-00085RUpdated Sep 17, 2026
- Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with StentingNational analysisReview closedCAG-00085NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Precise Nitinol", any status and sponsor, newest update first.
Cordis US Corp.Not on our public-company list
NCT07204678 · 199 participants · Start Oct 30, 2025 · Primary completion Feb 27, 2026
Device: PRECISE PRO Rx Nitinol Stent System · For: Carotid Artery Stenosis
Sites: Tulln, Austria; Bordeaux, France; Castel Volturno, Italy · 4 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Precise Nitinol", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIM
2,799 reports: 1,699 malfunction, 994 injury, 98 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1257-2021 · Started Feb 11, 2021
Reason given: Distal tip may become separated from the lumen wire in specific lots.
Cause as FDA categorized it: Process control · Device type: Stent, Carotid (NIM)
3 more recall records with a free account
Published research
The most relevant PubMed records for "Precise Nitinol"[tiab]. The summary above synthesizes these.
- Symptomatic carotid stenosis in the setting of bilateral disease and coexisting carotid body tumor: management with a carotid stent and staged excision.
Smeds M, Jacobs D · Vascular · 2013
- Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients.
Massop D, Dave R, Metzger C, et al. · Catheter Cardiovasc Interv · 2009Multicenter Study
- [MRI of carotid stents: influence of stent properties and sequence parameters on visualization of the carotid artery lumen].
Straube T, Wolf S, Flesser A, et al. · Rofo · 2005Comparative Study, Evaluation Study
- Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study.
Katzen BT, Criado FJ, Ramee SR, et al. · Catheter Cardiovasc Interv · 2007Evaluation Study, Multicenter Study
- [Carotid angioplasty and stenting in patients with high-risk carotid stenosis].
Qi J, Liu JR, Chao M · Zhejiang Da Xue Xue Bao Yi Xue Ban · 2007English Abstract, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code NIM.
- XACT® Carotid Stent SystemAbbott Vascular, Inc. · PMA 2025
- ENROUTE Transcarotid Stent SystemBoston Scientific Corporation · PMA 2023
- Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2016
- Carotid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2024
- Acculink Carotid Stent System and Rx Acculink Carotid Stent SystemAbbott Vascular · PMA 2017
- Roadsaver/CASPER Carotid Stent DeviceMicroVention, Inc. · PMA 2025
- Cartoid Wallstent Monorail EndoprosthesisBoston Scientific Corp · PMA 2012
- Protege Gps & Protege Rx Carotid Stent SystemsMedtronic Vascular, Inc. · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.